The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.

Krysiak, Robert; Kowalcze, Karolina; Okopien, Boguslaw

Krysiak, Robert; Kowalcze, Karolina; Okopien, Boguslaw.

Affiliation

Krysiak R; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
Kowalcze K; Department of Pediatrics in Bytom, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Okopien B; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.

Pharmacology ; 108(5): 451-459, 2023.

Article in En | MEDLINE | ID: mdl-37536301

Subject(s)

Cardiovascular Diseases; Insulin Resistance; Polycystic Ovary Syndrome; Humans; Female; Atorvastatin/therapeutic use; Atorvastatin/pharmacology; Polycystic Ovary Syndrome/drug therapy; Polycystic Ovary Syndrome/complications; Androgens; C-Reactive Protein/analysis; C-Reactive Protein/metabolism; Uric Acid; Cardiometabolic Risk Factors; Siblings; Risk Factors; Cardiovascular Diseases/etiology; Cardiovascular Diseases/prevention & control; Testosterone; Fibrinogen/analysis

Key words

Insulin sensitivity; Pleiotropic effects; Polycystic ovary syndrome; Risk factors; Statins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Insulin Resistance / Cardiovascular Diseases Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Pharmacology Year: 2023 Document type: Article Affiliation country: Poland Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google